A new health-care reform agenda puts antitrust at the center, targeting the conglomerates that dominate insurance, pharmacies, and providers. But breaking up Big Medicine leaves deeper problems intact, from profit-driven denial and risk selection to the administrative costs of a fragmented system.
In a Nutshell
The continent’s firms have overhauled their leadership in recent years
What we can learn from the influential economist who turns 90 next month
Exposure to Aston Martin and Altice International has weighed on fund run by 35-year-old Hamza Lemssouguer
Square Mile’s governing body considers allowing companies to display their logos on the top of offices for the first time
Traditionally conservative trustees ‘uncomfortable’ with digital assets due to their volatility, opacity and lack of regulation
Regulators say they want listings to remain priced cheaply amid push to boost investors’ faith in stock markets
The 10-year yield rose to its highest level in three years, suggesting investors were underwhelmed by the details of a move to buy back government bonds.
Trade unions have called on chancellor John Healey and PM to target banks in next month’s fiscal event
Move by world’s largest stablecoin issuer comes as market faces challenging conditions
